Kontoghiorges, G. J: Risks and benefits in the use of the iron chelating drugs deferiprone (L1) and deferoxamine and of the experimental iron chelators ICL670 (deferasirox), GT56-252 and L1NAII, for the treatment of iron overload and other metal toxicities : 7th International Symposium on Chelating Agents in Biomedicine, Toxicology and Therapeutics, July 8. - 11.2004, Pilsen, Czech Republic. Abstract